NO20050352L - Medikament for forhindring og/eller behandling av konstipasjon og symptomer pa konstipasjon - Google Patents

Medikament for forhindring og/eller behandling av konstipasjon og symptomer pa konstipasjon

Info

Publication number
NO20050352L
NO20050352L NO20050352A NO20050352A NO20050352L NO 20050352 L NO20050352 L NO 20050352L NO 20050352 A NO20050352 A NO 20050352A NO 20050352 A NO20050352 A NO 20050352A NO 20050352 L NO20050352 L NO 20050352L
Authority
NO
Norway
Prior art keywords
constipation
medication
treatment
symptoms
prevention
Prior art date
Application number
NO20050352A
Other languages
English (en)
Norwegian (no)
Inventor
Hideo Kato
Osamu Nagata
Hiroyuki Nakano
Yasushi Okamoto
Ippei Tanaka
Tadasho Inoue
Tsutomu Inoue
Jun-Ichiro Uda
Original Assignee
Fuji Yakuhin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Yakuhin Co Ltd filed Critical Fuji Yakuhin Co Ltd
Publication of NO20050352L publication Critical patent/NO20050352L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/78Polymers containing oxygen of acrylic acid or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20050352A 2002-06-26 2005-01-21 Medikament for forhindring og/eller behandling av konstipasjon og symptomer pa konstipasjon NO20050352L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002185790 2002-06-26
JP2003010905 2003-01-20
PCT/JP2003/008124 WO2004002499A1 (ja) 2002-06-26 2003-06-26 便秘及び便秘に伴う症状の予防及び/又は治療のための医薬

Publications (1)

Publication Number Publication Date
NO20050352L true NO20050352L (no) 2005-01-21

Family

ID=30002286

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050352A NO20050352L (no) 2002-06-26 2005-01-21 Medikament for forhindring og/eller behandling av konstipasjon og symptomer pa konstipasjon

Country Status (14)

Country Link
US (1) US20060051314A1 (de)
EP (1) EP1516623A1 (de)
JP (1) JP3662016B2 (de)
KR (1) KR20050046657A (de)
CN (1) CN1662247A (de)
AR (1) AR039750A1 (de)
AU (1) AU2003243986A1 (de)
BR (1) BR0312167A (de)
CA (1) CA2488039A1 (de)
MX (1) MXPA04012926A (de)
NO (1) NO20050352L (de)
RU (1) RU2005101768A (de)
TW (1) TW200404557A (de)
WO (1) WO2004002499A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101057861B (zh) * 2007-06-08 2010-07-28 广州朗圣药业有限公司 一种聚卡波菲肠溶药物组合物
CN105131159B (zh) * 2015-08-21 2017-05-31 浙江拓普药业股份有限公司 一种聚卡波非钙生产工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202577A (en) * 1962-05-25 1965-08-24 White Lab Inc Process of treating diarrhea with resins
NL129666C (de) * 1962-08-06
EP0273209B1 (de) * 1986-12-30 1992-01-15 American Cyanamid Company Zusammensetzung die ein Polycarbophil enthält
JP2609022B2 (ja) * 1990-11-29 1997-05-14 北陸製薬株式会社 ポリカルボフィルカルシウム含有製剤
ZA937277B (en) * 1992-09-30 1994-05-19 Ascent Pharma Inc Calsium polycarbophil sprinkle

Also Published As

Publication number Publication date
JPWO2004002499A1 (ja) 2005-10-27
CN1662247A (zh) 2005-08-31
BR0312167A (pt) 2005-03-29
CA2488039A1 (en) 2004-01-08
MXPA04012926A (es) 2005-05-16
AR039750A1 (es) 2005-03-09
EP1516623A1 (de) 2005-03-23
KR20050046657A (ko) 2005-05-18
TW200404557A (en) 2004-04-01
US20060051314A1 (en) 2006-03-09
AU2003243986A1 (en) 2004-01-19
JP3662016B2 (ja) 2005-06-22
RU2005101768A (ru) 2005-06-27
WO2004002499A1 (ja) 2004-01-08

Similar Documents

Publication Publication Date Title
HN2005000255A (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
UA89220C2 (ru) Способ лечения вич/спида путем приема без пищи или в условиях голодания твердого фармацевтического дозированного состава ингибитора вич-протеазы
WO2005082414A3 (en) Concomitant drugs of a sulfonamide and another therapeutic agent
MY145074A (en) Thiazolidin-4-one derivatives
NO20072542L (no) Pyrimidinderivat kondensert med ikke-aromatisk ring
BRPI0517088A (pt) formulação de comprimido estável
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
TN2016000230A1 (en) Orally disintegrating solid dosage unit containing an estetrol component.
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
DK1296972T3 (da) Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer
NO20084276L (no) Orodispergerbare domperidontabletter
NO20080248L (no) Tablett inneholdende lite opploselig, aktiv bestanddel
WO2005007137A3 (de) Ambroxolhaltige tabletten
NO20055631L (no) Doseringsform inneholdende pantoprazol som aktiv ingrediens
NO20061818L (no) Fremgangsmate for a inhibere remnant lipoproteinproduksjon
WO2005051350A3 (en) Water dispersible tablet
MY153109A (en) A solid pharmaceutical formulation
DK1355906T3 (da) 2H-1-benzopyranderivater, fremgangsmåder til deres fremstilling og farmaceutiske sammensætninger indeholdende dem
NO20050352L (no) Medikament for forhindring og/eller behandling av konstipasjon og symptomer pa konstipasjon
PA8549401A1 (es) Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient
NO20044091L (no) Anvendelse av substituerte 3-fenyl-5-alkoksy-1,3,4-oksdiazol-2-on for fremstilling av medikamenter som inhiberer pankreatisk lipase
WO2006076015A3 (en) 1-[2-(phosphonomethoxy)ethyl]-cytosine and analogs thereof
EP1362590A8 (de) Verwendung von Cilobradine oder pharmazeutisch akzeptablen Salze zur Behandlung oder Prävention von Herzversagen
TW200640446A (en) Prophylactic anti-stress agent

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application